Keywords: roche, mabthera, approved, cll, swiss, drug, major

Roche's MabThera approved for CLL

Article | 09 March 2009

Print This

Swiss drug major Roche says that the European Commission has approved MabThera (rituximab) in combination with chemotherapy for use in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in